Fibrinogen Saint-Germain II: Hypofibrinogenemia due to heterozygous γ N345S mutation

Thrombosis and Haemostasis

Volumn 94, Issue 5, 2005, Pages 965-968

  de Raucourt, Emmanuelle ^a   de Mazancourt, Philippe ^b   Maghzal, Ghassan J ^c   Brennan, Stephen O ^c   Mosesson, Michael W ^d  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c CANTERBURY HEALTH LABORATORIES   (New Zealand)

^d BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Hypofibrinogenemia; Thrombosis risk factors

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN; GLUTAMINE; GLYCINE; MUTANT PROTEIN; PROTHROMBIN; SERINE;

ADULT; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FIBRINOGEN BLOOD LEVEL; GENE MUTATION; HETEROZYGOSITY; HUMAN; HYPOFIBRINOGENEMIA; LEG DISEASE; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

ADULT; AFIBRINOGENEMIA; FIBRINOGENS, ABNORMAL; HETEROZYGOTE; HUMANS; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; VENOUS THROMBOSIS;

EID: 27844474755     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-05-0334     Document Type: Article

References (25)

1. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features ofibrinogen and fibrin. In: Nieuwenhuizen W, Mosesson MW de Maat MPM, editors. Fibrinogen. Ann NY Acad Sci 2001; 936: 11-30.
2. Mosesson MW. Fibrinogen gamma chain functions. J Thromb Haemost 2003; 1: 231-8.
3. Mosesson MW. Hereditary Fibrinogen Abnormalities. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, editors. Williams Hematology. New York: McGraw-Hill. 2005.
4. Mosesson MW. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost 2003; 89: 9-12.
5. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-6.
6. Bertina RM, Koeleman PC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
7. Raoul M, Mathonnet F, Peltier JY et al. An improved method for the detection of the G20210A transition in the prothrombin gene. Thromb Res 1997; 88: 441-3.
8. Mosesson MW, Sherry S. The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry 1966; 5: 2829-35.
9. Brennan SO, Electrospray ionisation analysis of human fibrinogen Thromb Haemost 1997; 78:1055-8.
10. Nelson C, Noelkan M, Buckley C, Tanford C, Hill R. Biochemistry. 1965; 4: 1418-26.
11. Meyer M, Franke K, Richter W et al. New molecular defects in the gamma subdomain of fibrinogen D-domain in four cases of (hypo)dysfibrinogenemia: fibrinogen variants Hannover VI, Homburg VII, Stuttgart and Suhl. Thromb Haemost 2003; 89: 637-46.
12. Brennan SO, Wyatt J, Medicina D et al. Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a gamma284 Gly - >Arg mutation. Am J Pathol 2000; 157: 189-96.
13. Brennan SO, Maghzal G, Shneider BL et al. Novel fibrinogen gamma375 Arg - >Trp mutation (fibrinogen Aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology 2002; 36: 652-8.
14. Brennan SO, Wyatt JM, Fellowes AP et al. Gamma371 Thr - >Ile substitution in the fibrinogen gamma D domain causes hypofibrinogenaemia. Biochim Biophys Acta 2001; 1550: 183-8
15. Brennan SO, Wyatt JM, May S et al. Hypofibrinogenemia due to novel 316 Asp - >Tyr substitution in the fibrinogen Bbeta chain. Thromb Haemost 2001; 85: 450-3.
16. Brennan SO, Fellowes AP, Faed JM et al. Hypofibrinogenemia in an individual with 2 coding (gamma82 A - >G and Bbeta235 P - >L) and 2 noncoding mutations. Blood 2000; 95: 1709-13
17. Wyatt J, Brennan SO, May S et al. Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - gamma 82 Ala - >Gly and an intron two GT->AT splice site mutation. Thromb Haemost 2000;84:449-52
18. Caen J, Faur Y, Inceman S et al. Nécrose ischémique bilatérale dans un cas de grande hypofibrinogénémie congénitale. Nouv Rev Fr Hématol 1964; 4: 321-6.
19. Marchal G, Duhamel G, Samama M et al. Thrombose massive des vaisseaux d'un membre an cours d'une hypofibrinémie congénitale. Hémostase 1964; 4: 81-9.
20. Nilsson IM, Niléhn J-E, Cronberg S et al. Hypofibrinogenemia and massive thrombosis. Acta Medica Scandinavica 1966; 180: 65-76.
21. Ingram GI, McBrien DJ, Spencer H. Fatal pulmonary embolism in congenital fibrinopenia. Acta Haematol 1966; 35: 56-62.
22. Chafa O, Chellali T, Sternberg C et al. Severe hypofibrinogenemia associated with bilateral ischemic necrosis of toes and fingers. Blood Coagul Fibrinolysis 1995;6:549-52.
23. Olds RJ, Fitches AC, Geary CPM, The multigenic basis for venous thrombosis. 2000. Br J Haematol 2000;109:508-11
24. Siebenlist KR, Mosesson MW, Meh DA et al. Co-existing dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids). Blood Coagul Fibrinolysis 2000; 11: 293-304.
25. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995; 73:151-61.